Nirsevimab (Beyfortus)

For the first time, a preventative medicine is available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV). Lori Handy, MD, MSCE, attending…

Definitive Therapies for Immunodeficiency

At the end of this session, learners will be able to understand definitive therapies for immunodeficiency and the workflow for utilization of definitive therapies with…

Precision Medicine in Immunodeficiency

At the end of this session, learners will be able to discuss the medical management of pediatric patients with immunodeficiency through utilization of immunoglobulin replacement,…